Sandbox Reserved 432

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
('''Sulfonylpiperidine ligand as Thymidylate Kinase Inhibitor''')
Line 8: Line 8:
==Introduction==
==Introduction==
-
Thymidylate kinase or TMK is found in methicillin-resistant Staphylococcus aureus or MRSA and has been targeted as a possible target for antibacterial drugs. TMK is essential for DNA synthesis as it phosphorylates deoxythymidine monophosphate to deoxythymidine diphosphate [1]. One reason that TMK has been targeted for antibacterial drugs are the structural differences between human and bacterial TMK's. These structural differences could possibly minimize long term resistance to the drug from the bacteria. One of the conformational differences between human and bacterial TMK's has to do with the difference in the TMP-binding site of SaTMK at the base of the TMP-binding cavity [1]. The <scene name='48/483889/Alpha_helices/1'>basic structure</scene> of TMK can be seen here. In order to establish enzyme affinity hydrogen bonds were formed between Arginine48 and TMK is MRSA thus allowing for possible target sites for drugs to be identified [1]. This is shown in this <scene name='48/483889/Arginine_sites/1'>Figure</scene> where the black sticks are the sites that have identified as being positively charged, and the blue ribbons are where Arginine has been identified and thus a possible source of attachment for a drug or enzyme.
+
Thymidylate kinase or TMK is found in methicillin-resistant Staphylococcus aureus or MRSA and has been targeted as a possible target for antibacterial drugs. TMK is essential for DNA synthesis as it phosphorylates deoxythymidine monophosphate to deoxythymidine diphosphate [2]. One reason that TMK has been targeted for antibacterial drugs are the structural differences between human and bacterial TMK's. These structural differences could possibly minimize long term resistance to the drug from the bacteria. One of the conformational differences between human and bacterial TMK's has to do with the difference in the TMP-binding site of SaTMK at the base of the TMP-binding cavity [2]. The <scene name='48/483889/Alpha_helices/1'>basic structure</scene> of TMK can be seen here. In order to establish enzyme affinity hydrogen bonds were formed between Arginine48 and TMK is MRSA thus allowing for possible target sites for drugs to be identified [2]. This is shown in this <scene name='48/483889/Arginine_sites/1'>Figure</scene> where the black sticks are the sites that have identified as being positively charged, and the blue ribbons are where Arginine has been identified and thus a possible source of attachment for a drug or enzyme.
Line 23: Line 23:
==Additional Features==
==Additional Features==
'''Substrate Binding''':
'''Substrate Binding''':
-
Thymidylate kinase is associated with pyrimidine metabolism and deoxythymidine trisphosphate (dTTP) biosynthesis. Its catalytic activity is responsible for the conversion of deoxythymidine monophosphate (dTMP) and ATP into deoxythymidine diphosphate (dTDP) and ADP through phosphoryl transfer. Deoxythymidine trisphosphate is a key component in the synthesis of DNA. By inhibiting the formation of dTDP, dTTP cannot be synthesized and thus DNA synthesis is halted. A key difference in the substrate-binding site of MRSA-TMK compared to other species is the base of the TMP binding cavity, where the ''cis''-proline that forms the base for other species is turned to instead provide a space for <scene name='48/483889/Arg_48_positioning/2'>Arg 48</scene> to link to Glu 37 of the main chain and form a new TMP binding site base.
+
Thymidylate kinase is associated with pyrimidine metabolism and deoxythymidine trisphosphate (dTTP) biosynthesis. Its catalytic activity is responsible for the conversion of deoxythymidine monophosphate (dTMP) and ATP into deoxythymidine diphosphate (dTDP) and ADP through phosphoryl transfer. Deoxythymidine trisphosphate is a key component in the synthesis of DNA. By inhibiting the formation of dTDP, dTTP cannot be synthesized and thus DNA synthesis is halted [2]. A key difference in the substrate-binding site of MRSA-TMK compared to other species is the base of the TMP binding cavity, where the ''cis''-proline that forms the base for other species is turned to instead provide a space for <scene name='48/483889/Arg_48_positioning/2'>Arg 48</scene> to link to Glu 37 of the main chain and form a new TMP binding site base [2].
Certain TMK binding residues are conserved throughout all species (<scene name='48/483889/Conserved_tmk_binding_residues/2'>Shown Here</scene>):
Certain TMK binding residues are conserved throughout all species (<scene name='48/483889/Conserved_tmk_binding_residues/2'>Shown Here</scene>):
Line 60: Line 60:
==References==
==References==
<references/>
<references/>
-
[1] Kotaka M, Dhaliwal B, Ren J, et al. Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding. Protein Science : A Publication of the Protein Society. 2006;15(4):774-784. doi:10.1110/ps.052002406.
+
2. Kotaka M, Dhaliwal B, Ren J, et al. Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding. Protein Science : A Publication of the Protein Society. 2006;15(4):774-784. doi:10.1110/ps.052002406.

Revision as of 10:27, 3 April 2015


This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439.


Sulfonylpiperidine Ligand as Thymidylate Kinase Inhibitor

4hld, Sulfonylpiperidine Ligand as Thymidylate Kinase Inhibitor

Drag the structure with the mouse to rotate
Personal tools